FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 358:2061-2063 May 8, 2008 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article Related Article by The HAPO Study Cooperative Research Group Related Article by Rowan, J. A. PubMed Citation

Pregnancy is associated with relative carbohydrate intolerance and insulin resistance. Gestational diabetes mellitus (carbohydrate intolerance first diagnosed during pregnancy) has long been recognized as a risk factor for a number of adverse outcomes during pregnancy, including excessive fetal growth, an increased incidence of birth trauma and cesarean delivery, and neonatal metabolic abnormalities such as polycythemia, hyperbilirubinemia, and hypoglycemia.¹ This recognition has led to recommendations to screen all pregnant women for gestational diabetes mellitus and to treat those whose glucose-tolerance tests exceed threshold criteria.²

The threshold criteria for diagnosing gestational diabetes were initially specified rather arbitrarily as values greater than 2 . . . [Full Text of this Article]

Source Information

From Harvard Medical School and Massachusetts General Hospital — both in Boston.

This article has been cited by other articles:

• (2008). Gestational Hyperglycemia: Continuum of Risk, Choices for Treatment. JWatch Women's Health 2008: 1-1 [Full Text]  
• (2008). Gestational Diabetes: Controversies About Diagnosis and Treatment Persist. JWatch General 2008: 1-1 [Full Text]